title: Follicular dendritic cell immunohistochemical markers in angioimmunoblastic T-cell lymphoma.
abstract: Angioimmunoblastic T-cell lymphoma is characterized by a paracortical proliferation of medium to large neoplastic T cells, often with clear cytoplasm, in a background of arborizing high endothelial venules, many surrounded by follicular dendritic cells (FDCs). IHC staining may be applied to highlight these extrafollicular FDCs, traditionally using CD21, or CD23. Several alternative FDC markers have been described, including CNA.42, cystatin A/acid cysteine proteinase inhibitor (ACPI, involved in antigen presentation), and fascin (an actin binding protein). The authors stained a collection of 45 angioimmunoblastic T-cell lymphomas with CD21, CD23, CNA.42, cystatin A, and fascin for direct comparison of FDC staining characteristics in this setting. CD21 highlighted the expected dendritic network of cell processes, within residual follicles and outside of follicles, often adjacent to proliferating vessels. CD23 exhibited similar staining quality but was less sensitive than CD21. CNA.42 showed only diffuse weak labeling of FDCs. Cystatin A stained the cytoplasm of follicular dendritic cells within and outside of follicles; however, staining was often not sharply localized to dendritic cell processes, and scoring was further complicated by reactivity with other cell types in over half of the cases. Likewise, fascin stained a variety of cell types, including strong staining of interdigitating dendritic-like cells, moderate staining of endothelial cells, and only weak staining of follicular dendritic cells within and outside of follicles. Thus, CD21 remains the most reliable marker of follicular dendritic cells in angioimmunoblastic T-cell lymphoma.
authors.affiliation: Department of Pathology, Stanford University School of Medicine, CA 94305, USA.
authors.forename: Megan L
authors.initials: ML
authors.lastname: Troxell
authors.forename: Erich J
authors.initials: EJ
authors.lastname: Schwartz
authors.forename: Matt
authors.initials: M
authors.lastname: van de Rijn
authors.forename: Douglas T
authors.initials: DT
authors.lastname: Ross
authors.forename: Roger A
authors.initials: RA
authors.lastname: Warnke
authors.forename: John P
authors.initials: JP
authors.lastname: Higgins
authors.forename: Yasodha
authors.initials: Y
authors.lastname: Natkunam
mesh_terms: D000954:Antigens, Surface / Q000096:biosynthesis*; D002352:Carrier Proteins / Q000276:immunology; D015891:Cystatins / Q000276:immunology; D015853:Cysteine Proteinase Inhibitors / Q000276:immunology; D020566:Dendritic Cells, Follicular / Q000276:immunology* / Q000473:pathology*; D042783:Endothelial Cells / Q000276:immunology; D006801:Humans; D007150:Immunohistochemistry; D016399:Lymphoma, T-Cell / Q000276:immunology / Q000473:pathology*; D008840:Microfilament Proteins / Q000276:immunology; D017464:Receptors, Complement 3d / Q000276:immunology; D017455:Receptors, IgE / Q000276:immunology
chemical_list: D000954:Antigens, Surface; D002352:Carrier Proteins; D015891:Cystatins; D015853:Cysteine Proteinase Inhibitors; D008840:Microfilament Proteins; D017464:Receptors, Complement 3d; D017455:Receptors, IgE; C020324:fascin